May 2012 Editor's Picks: Products from Koslow Scientific Company and Vaisala - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

May 2012 Editor's Picks: Products from Koslow Scientific Company and Vaisala

Equipment and Processing Report

Featured products from Pharmaceutical Technology's monthly newsletter, Equipment & Processing Report

Koslow Scientific Company
Portable tester verifies passivation of stainless-steel equipment

Koslow Scientific Company’s Passi-Flash 3036 portable instrument for passivation testing works with all grades of stainless steel to verify that vessels, piping, and equipment are free from iron particles that can oxidize and contaminate products. The tester resembles an oversized pen and is designed for single-handed operation. It produces a pass/fail signal in less than one second and displays the measurement in millivolts. The built-in memory stores readings for download to a record-keeping system. Portable testers allow users to test equipment on-site, rather than at an outside testing facility, notes the company.


Vaisala
Cold chain logger records time and temperature data

Vaisala’s CCL100 Cold Chain Logger records and monitors time and temperature during transportation of vaccines, pharmaceuticals, biologics, and other perishable products. The thin, compact, single-use sensor can be placed inside or on top of a package where it reads and records surface temperature throughout the cold chain. The new logger is in a sealed, waterproof package that is smaller than existing packages. The logger features a simple delivery system that does not require special readers or software, but connects to a USB port to generate a comprehensive report of the package’s history. A flashing LED on the logger alerts operators to any temperature excursions.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes
Sandoz Wins Biosimilar Filing Race
Source: Equipment and Processing Report,
Click here